0% placebo) Headache (reported in at least 10% with bremelanotide) Local injection reactions: pain, redness, swelling Dizziness or lightheadedness Temporary increases in blood pressure Mild-to-moderate fatigue or malaise Rare but serious events include pronounced hypertensive episodes, severe allergic reactions, syncope, and less well-documented cardiac events in people with underlying heart disease
Proper reconstitution also depends on using a verified vital prep sterile solution to preserve peptide integrity
NPRA cited Amalan Perkilangan Baik, the Malay for good manufacturing practice, as an example of a name prohibited under the updated rules
Edukafarm was founded in 1999 and is the leading educational institute for medical and pharmacotherapy education in the EU
Garvey et al., 2023 SURMOUNT-2 (With Type 2 Diabetes) Garvey and colleagues reported SURMOUNT-2 in The Lancet in 2023 [8]
The disease burden of migraine patients receiving prophylactic treatments in Korea: a population-based claims database analysis